Search - tctmd.com

Displaying 261 - 280 of 457

Sort: Relevancy | Date

News Daily News

PARTNER 2A at EACTS 2019: ‘The Message Is Exactly the Same’

Shelley Wood

October 08, 2019

News Conference News TCT 2019

TAVR Improves Health Status Over Surgery in Low-Risk Patients at 1 Year: PARTNER 3

Yael L. Maxwell

September 29, 2019

News Conference News TCT 2019

Transcatheter Options Best for Tricuspid Regurgitation in Matched Registry Analysis

Michael O'Riordan

September 27, 2019

News Conference News TCT 2019

Transseptal Transcatheter Mitral Valve-in-Valve Ups Survival in High-Risk Patients

Yael L. Maxwell

September 27, 2019

News Conference News TCT 2019

TCT 2019: Pharmacotherapy in PCI, Head-to-Head Valves, YouTube Rappers, and More

Shelley Wood

September 19, 2019

News Daily News

Surgical Bailout Rarely Needed Though Can Save Lives: TVT Registry

Yael L. Maxwell

September 18, 2019

News Conference News ESC 2019

LAA Occluders, NOACs Provide Similar Outcomes in High-risk A-fib Patients: PRAGUE-17

Todd Neale

September 10, 2019

News Industry News

Abbott Launches World's First Pivotal Trial To Test New Approach For Repairing Leaky Tricuspid Heart Valves

September 05, 2019

News Daily News

VA Medical Centers’ Quality Measures for TAVR Pay Off

Caitlin E. Cox

August 30, 2019

News Daily News

MIDAS Touch: Anatomic Strategy Dramatically Lowers Pacemaker Rate With Evolut Valves

Michael O'Riordan

August 29, 2019

News Daily News

Aborted TAVR Procedures Are Waning in the US

Shelley Wood

August 28, 2019

News Conference News ESC 2019

ESC 2019: Antiplatelets in Diabetes, CAD and A-fib, an ARNI in HFpEF, Staged Complete PCI, and More

Shelley Wood

August 22, 2019

News Daily News

Antiplatelets Protective Post-TAVR in A-fib Patients: PARTNER II Data

Caitlin E. Cox

August 21, 2019

News Daily News

CMS Opens a Review of Coverage for Transcatheter Mitral Valve Repair

Todd Neale

August 20, 2019

News Industry News

Medtronic Evolut TAVR System Receives Expanded Indication to Treat Symptomatic Severe Aortic Stenosis Patients at Low Risk for Surgical Mortality

August 16, 2019

News Daily News

Better Outcomes, Fewer Complications Among Higher-Volume MitraClip Sites

Michael O'Riordan

July 17, 2019

News Daily News

Evolut Valves: Initial Positioning Can Be Optimized for Future Coronary Access

Michael O'Riordan

July 10, 2019

News Industry News

Correvio Resubmits Brinavess (Vernakalant) New Drug Application to U.S. FDA for the Treatment of Patients with Recent Onset Atrial Fibrillation

June 24, 2019

News Conference News TVT 2019

Better Hemodynamics, Less Mismatch With Self-Expanding TAVR vs Surgery

Michael O'Riordan

June 20, 2019

News Conference News TVT 2019

Surgical Risk Should Be ‘Off the Table’ When Deciding on Eligibility for TAVR

Michael O'Riordan

June 19, 2019

Advertisement

PARTNER 2A at EACTS 2019: ‘The Message Is Exactly the Same’

TAVR Improves Health Status Over Surgery in Low-Risk Patients at 1 Year: PARTNER 3

Transcatheter Options Best for Tricuspid Regurgitation in Matched Registry Analysis

Transseptal Transcatheter Mitral Valve-in-Valve Ups Survival in High-Risk Patients

TCT 2019: Pharmacotherapy in PCI, Head-to-Head Valves, YouTube Rappers, and More

Surgical Bailout Rarely Needed Though Can Save Lives: TVT Registry

LAA Occluders, NOACs Provide Similar Outcomes in High-risk A-fib Patients: PRAGUE-17

Abbott Launches World's First Pivotal Trial To Test New Approach For Repairing Leaky Tricuspid Heart Valves

VA Medical Centers’ Quality Measures for TAVR Pay Off

MIDAS Touch: Anatomic Strategy Dramatically Lowers Pacemaker Rate With Evolut Valves

Aborted TAVR Procedures Are Waning in the US

ESC 2019: Antiplatelets in Diabetes, CAD and A-fib, an ARNI in HFpEF, Staged Complete PCI, and More

Antiplatelets Protective Post-TAVR in A-fib Patients: PARTNER II Data

CMS Opens a Review of Coverage for Transcatheter Mitral Valve Repair

Medtronic Evolut TAVR System Receives Expanded Indication to Treat Symptomatic Severe Aortic Stenosis Patients at Low Risk for Surgical Mortality

Better Outcomes, Fewer Complications Among Higher-Volume MitraClip Sites

Evolut Valves: Initial Positioning Can Be Optimized for Future Coronary Access

Correvio Resubmits Brinavess (Vernakalant) New Drug Application to U.S. FDA for the Treatment of Patients with Recent Onset Atrial Fibrillation

Better Hemodynamics, Less Mismatch With Self-Expanding TAVR vs Surgery

Surgical Risk Should Be ‘Off the Table’ When Deciding on Eligibility for TAVR

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content